PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New gut-brain discovery offers hope for treating ALS and dementia

Breakthrough study identifies harmful bacterial sugar as potential therapeutic target for neurodegenerative diseases

2026-02-09
(Press-News.org) CLEVELAND—A significant discovery by Case Western Reserve University researchers could change how doctors treat two of the most devastating neurodegenerative diseases.

The team identified a link between gut bacteria and the deterioration of the brain in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The researchers discovered that certain bacterial sugars cause immune responses that kill cells—and how to prevent it.

FTD mainly affects the brain’s frontal and temporal lobes, causing changes in a person’s personality, behavior and language. ALS primarily targets motor neurons, resulting in gradual muscle weakness and paralysis.

Most causes of ALS and FTD cases are unknown, although researchers have been examining several potential reasons, including genetics, environmental issues, brain injuries and diet.
The study, recently published in Cell Reports, solves a long-standing question about neurodegenerative diseases. The team discovered a molecular connection that explains why some people with specific genetic mutations acquire FTD and ALS and others don’t.

“We found that harmful gut bacteria produce inflammatory forms of glycogen (a type of sugar), and that these bacterial sugars trigger immune responses that damage the brain,” said Aaron Burberry, assistant professor in the Department of Pathology at the Case Western Reserve School of Medicine.

Burberry, the study’s senior investigator, reported that 70% of the 23 ALS/FTD patients examined had dangerous glycogen levels. Of those without the brain diseases, only a third had high levels of glycogen.

The study has immediate implications for patient care by identifying new targets to treat ALS and FTD, while providing biomarkers to identify patients who might benefit from gut-targeted therapies.

This discovery paves the way for testing new treatments that break down harmful sugars in the gut, and it opens doors for developing drugs that work on the connection between the digestive system and the brain—potentially offering new hope for patients suffering from these devasting brain diseases.

Alex Rodriguez-Palacios, assistant professor in the Digestive Health Research Institute at the School of Medicine, said the team used its findings to then reduce the harmful sugars, which “improved brain health and extended lifespan.”

Their discovery is particularly significant for what is known as C90RF72 mutation carriers—the most common genetic cause of ALS and FTD. The research explains why some people with the mutation develop the diseases while others don’t, identifying gut bacteria as a key environmental trigger.

The university’s Department of Pathology and Digestive Health Research Institute are leading neurovegetative disease research through their unique ability to conduct studies using germ-free mouse models—mice raised in completely sterile environments with no bacteria, allowing researchers to study exactly how specific gut bacteria affect brain diseases.

Fabio Cominelli, Distinguished University Professor and director of the Digestive Health Research Institute, oversees this program, which relies on an innovative “cage-in-cage” sterile housing system developed by Rodriguez-Palacios—a technical capability that few institutions worldwide possess and that made this discovery possible.

The design makes possible the large-scale microbiological studies necessary to understand the complex communication between the gut and brain—research that would be impossible with traditional methods that can only accommodate a few mice at a time, and a technical capability that few institutions worldwide possess.

“To understand when and why harmful microbial glycogen is produced, the team will next conduct larger studies surveying gut microbiome communities in ALS/FTD patients before and after disease onset,” Burberry said. “Clinical trials to determine whether glycogen degradation in ALS/FTD patients could slow disease progression are also supported by our findings and could begin in a year.”

###

About Case Western Reserve University

As one of the fastest-growing research universities in the United States, Case Western Reserve University is a force in career-defining education and life-changing research. Across our campus, more than 12,000 students from around the world converge to seek knowledge, find solutions and accelerate their impact. They learn from and collaborate with faculty members renowned for expertise in medicine, engineering, science, law, management, dental medicine, nursing, social work, and the arts. And with our location in Cleveland, Ohio—a hub of cultural, business and healthcare activity—our students gain unparalleled access to academic, research, clinical and entrepreneurial opportunities that prepare them to join our network of more than 125,000 alumni worldwide. Visit case.edu to see why Case Western Reserve University is built for those driven to be a force in the world.

END



ELSE PRESS RELEASES FROM THIS DATE:

Cognitive speed training linked to lower dementia incidence up to 20 years later

2026-02-09
FOR IMMEDIATE RELEASE Adults age 65 and older who completed five to six weeks of cognitive speed training — in this case, speed of processing training, which helps people quickly find visual information on a computer screen and handle increasingly complex tasks in a shorter time period — and who had follow-up sessions about one to three years later were less likely to be diagnosed with dementia, including Alzheimer’s disease, up to two decades later, according to new findings published today in Alzheimer’s & Dementia: Translational Research and Clinical Interventions. This National Institutes of Health ...

Businesses can either lead transformative change or risk extinction: IPBES

2026-02-09
Manchester, UK —  Every business depends on biodiversity, and every business impacts biodiversity. The growth of the global economy has been at the cost of immense biodiversity loss, which now poses a critical and pervasive systemic risk to the economy, financial stability and human wellbeing. This is a central finding of a landmark new report published today by the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES). Even companies that might seem far-removed from nature or that do not see themselves as nature-based rely, directly or indirectly, on material inputs, regulation of environmental conditions - such as ...

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

2026-02-09
The signals that drive many of the brain and body’s most essential functions—consciousness, sleep, breathing, heart rate and motion—course through bundles of “white matter” fibers in the brainstem, but imaging systems so far have been unable to finely resolve these crucial neural cables. That has left researchers and doctors with little capability to assess how they are affected by trauma or neurodegeneration. In a new study, a team of MIT, Harvard, and Massachusetts General Hospital researchers unveil AI-powered software capable of automatically segmenting eight distinct bundles in any ...

Dr. Paul Donlin-Asp of the University of Edinburgh to dissect the molecular functions and regulation of local SYNGAP1 protein synthesis with support from CURE SYNGAP1 (fka SynGAP Research Fund)

2026-02-09
Mill Valley, CA – February 3, 2026 – CURE SYNGAP1 (fka SynGAP Research Fund), a 501(c)(3) organization, announces a $130,000 grant to Dr. Paul Donlin-Asp, PhD, of the Simons Initiative for the Developing Brain (SIDB) at The University of Edinburgh. The grant supports his work in investigating the molecular functions and regulation of local SYNGAP1 protein synthesis, with the goal of advancing therapies for SYNGAP1-Related Disorders (SRD). Why We Supported This Project Dr. Donlin-Asp’s research focuses on a critical aspect of SRD: the production of SYNGAP1 protein at synapses, which plays a key role in regulating ...

Seeing the whole from a part: Revealing hidden turbulent structures from limited observations and equations

2026-02-09
The irregular, swirling motion of fluids we call turbulence can be found everywhere, from stirring in a teacup to currents in the planetary atmosphere. This phenomenon is governed by the Navier–Stokes equations—a set of mathematical equations that describe how fluids move. Despite being known for nearly two centuries, these equations still pose major challenges when it comes to making predictions. Turbulent flows are inherently chaotic, and tiny uncertainties can grow quickly over time. In real-world situations, scientists can only observe part of a turbulent flow, usually its largest and slowest ...

Unveiling polymeric interactions critical for future drug nanocarriers

2026-02-09
Polymer micelles are tiny, self-assembled particles that are revolutionizing the landscape of drug delivery and nanomedicine. They form when polymer chains containing both hydrophilic and hydrophobic segments organize into nanoscale spheres in liquid solutions; these structures can trap and hold drugs that are otherwise difficult to dissolve. Poloxamer 407 (P407), a widely studied micelle-forming polymer, is particularly useful because it changes from a liquid into a soft gel as it warms, becoming most stable near body temperature. This temperature-dependent gelling behavior ...

New resource supports trauma survivors, health professionals  

2026-02-09
A new digital resource co-created by University of Victoria (UVic) researchers and trauma survivors will streamline access to resources and tools for clinicians who support people with complex post-traumatic stress at Island Health in B.C. and other jurisdictions.  To enhance trauma-informed health care for people experiencing complex post-traumatic stress disorder (C-PTSD), an online site has been built to provide the information and tools professionals need to respond to emerging patient care needs. Using multimedia including videos, handouts and quizzes, the tool provides information on C-PTSD, how it affects people mentally ...

Evidence of a subsurface lava tube on Venus

2026-02-09
Volcanic activity is not unique to Earth: traces of volcanic activity, such as lava tubes, have been found on Mars and the Moon. Now, the University of Trento has demonstrated the existence of an empty lava tube even in the depths of Venus, a planet whose surface and geology have been largely shaped by volcanic processes. The cave was identified through radar data analysis as part of a project funded by the Italian Space Agency. The discovery was published by Nature Communications. "Our knowledge of Venus is still limited, and until now we have never had the opportunity to directly observe processes occurring beneath the surface of Earth’s twin planet. ...

New trial aims to transform how we track our daily diet

2026-02-09
Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in their daily lives. The findings of their research could pave the way for better public health strategies to tackle diseases linked to poor diets such as type 2 diabetes, heart disease and some cancers. Currently diets are measured by people completing complex and time-consuming nutrition surveys themselves and trying to remember exactly what they have eaten, but this can lead ...

People are more helpful when in poor environments

2026-02-09
People are more likely to act helpfully in situations where there are poorer choices to give to others, according to a new study that tested willingness to help others in different contexts. The paper, published in Nature Communications today (Monday 9 February), is the culmination of three studies involving more than 500 participants and led by academics from the University of Birmingham. The team, which also included academics from Oxford University and the University of East Anglia, found that when people were in a poor environment they were surprisingly more likely to help compared to the richer environment. Dr ...

LAST 30 PRESS RELEASES:

Let’s get on pancreatic cancer’s nerves

Intermittent fasting cut Crohn’s disease activity by 40% and halved inflammation in randomized clinical trial

New study in JNCCN unlocks important information about how to treat recurring prostate cancer

Simple at-home tests for detecting cat, dog viruses

New gut-brain discovery offers hope for treating ALS and dementia

Cognitive speed training linked to lower dementia incidence up to 20 years later

Businesses can either lead transformative change or risk extinction: IPBES

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

Dr. Paul Donlin-Asp of the University of Edinburgh to dissect the molecular functions and regulation of local SYNGAP1 protein synthesis with support from CURE SYNGAP1 (fka SynGAP Research Fund)

Seeing the whole from a part: Revealing hidden turbulent structures from limited observations and equations

Unveiling polymeric interactions critical for future drug nanocarriers

New resource supports trauma survivors, health professionals  

Evidence of a subsurface lava tube on Venus

New trial aims to transform how we track our daily diet

People are more helpful when in poor environments

How big can a planet be? With very large gas giants, it can be hard to tell

New method measures energy dissipation in the smallest devices

More than 1,000 institutions worldwide now partner with MDPI on open access

Chronic alcohol use reshapes gene expression in key human brain regions linked to relapse vulnerability and neural damage

Have associations between historical redlining and breast cancer survival changed over time?

Brief, intensive exercise helps patients with panic disorder more than standard care

How to “green” operating rooms: new guideline advises reduce, reuse, recycle, and rethink

What makes healthy boundaries – and how to implement them – according to a psychotherapist

UK’s growing synthetic opioid problem: Nitazene deaths could be underestimated by a third

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

[Press-News.org] New gut-brain discovery offers hope for treating ALS and dementia
Breakthrough study identifies harmful bacterial sugar as potential therapeutic target for neurodegenerative diseases